The Global Blood Gas and Electrolyte Analyzer Market size is estimated to be USD 3.57 Billion in 2019 and is predicted to reach USD 6.24 Billion by 2030 with a CAGR of 5.2% from 2020-2030.
The blood gas and electrolyte analyzer is a medical device used to detect diabetes, blood vessel hemorrhage, drug overdose and shock. It also determines the abnormal metabolite & levels of electrolytes in blood along with the levels of oxygen/carbon dioxide exchange and the pH balance. Blood gas analyzers are utilized to test several parameters including O2 concentration, hydrogen ion and others.
Top Companies: Radiometer Medical Aps (A Subsidiary of Danaher Corporation), Instrumentation Laboratory (A Werfen Company), Siemens AG, Roche Diagnostics Limited, Abbott Laboratories, Inc., Nova Biomedical, OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.), ERBA Diagnostics Mannheim GmbH, Medica Corporation and Alere, Inc and others.
Access Full Description of this report at:-
Blood gas and electrolyte analyzer market report is segmented on the basis of type, product/ brand, end user and geography. Based on type, the market is segmented into analyzers/ instruments, and consumables. Based on product/ brand, the market is segmented into i-STAT, GEM Premier, ABL Flex, RAPID Series, Cobas, and others. Based on end users, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers, and others. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
The consistent upsurge in the elderly population has lead to upsurge in number of patients in emergency departments, critical care units and operating rooms receiving critical care. This is the key driver of the blood gas and electrolyte analyzer market growth. According to WHO the global population of the age group 65 years and above is estimated to increase to 16% by 2050 which further assures the market growth. Other factors such as technological developments and approved product launches are estimated to propel the growth of the market. However, complexity in blood analysis data interpretation may hinder the market growth. Consequently, the rising investments and growth of healthcare industry are estimated to provide lucrative opportunities for the market growth.
Request sample copy of this report at:-
North America holds the highest market size & share in the global blood gas and electrolyte analyzer market because of the well-developed healthcare industry and increasing number of patients. Rising government initiatives and hike in number of patients suffering from chronic diseases is estimated to cause significant growth in the market of Asia-Pacific.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com